100 Se 3rd Ave. Suite 1400 Fort Lauderdale, FL 33394
Note: Revenues for privately held companies are statistical evaluations.
United States Pharmaceutical Group's annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Merchant Wholesalers, Durable Goods industry.
United States Pharmaceutical Group's Annual Report & Profile shows critical firmographic facts:
What is the company's size? (Annual sales and employees)
What industry is the company in?
United States Pharmaceutical Group Annual Revenue and Growth Rate
Note: United States Pharmaceutical Group's revenues are gauged from an analysis of company filings.
United States Pharmaceutical Group's Income Statement (based on Industry Averages)
$ Millions (Industry Average)
United States Pharmaceutical Group Revenue (Sales)
Cost of Goods Sold
Salaries and wages
Other Operating Expenses
Total Operating Expenses
EBIT (Earnings Before Interest and Taxes)
Trademark applications show the products and services that United States Pharmaceutical Group is developing and marketing.
United States Pharmaceutical Group's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
CONVEY Medical claims processing software
CONVEY HEALTH SOLUTIONS TECHNOLOGY PEOPLE INNOVATION Business process outsourcing for healthcare businesses using licensed and un-licensed agents and proprietary technology; health plan member engagement services in the nature of appointment scheduling services
TECHNOLOGY. PEOPLE. INNOVATION Business process outsourcing for healthcare businesses using licensed and un-licensed agents and proprietary technology; health plan member engagement services in the nature of appointment scheduling services
Determine whether United States Pharmaceutical Group grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof United States Pharmaceutical Group is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
Market Share of United States Pharmaceutical Group's Largest Competitors
A competitive analysis shows these companies are in the same general field as United States Pharmaceutical Group, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to United States Pharmaceutical Group.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: United States Pharmaceutical Group's Fastest Growing Competitors
These companies are in the same general field as United States Pharmaceutical Group and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.